Califf Clears First Senate Hurdle, But Could FDA’s Abortion Pill Access Decision Be A Headache?
Robert Califf’s nomination to be the next US FDA commissioner squeaked out of the Senate health committee, but a significant number of Republicans are against his confirmation over the agency’s recent decisions on abortion drugs.
You may also be interested in...
REMS modification implemented for the duration of the pandemic will become permanent, the agency determines in response to lawsuit. FDA adds a requirement that pharmacies dispensing the drug be certified.
Robert Califf offers some interesting clues as to how he’d handle top drug policy issues in his Senate confirmation hearing.
After a mostly friendly round of questioning from members of the US Senate committee on health, the confirmation of President Joe Biden’s pick to lead the US FDA seems more likely.